Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy (HCM) has been informative as a genetic model of cardiac hypertrophy. Unexpectedly, analysis of the diverse sarcomeric mutations that typically cause HCM has implicated energetic compromise in pathogenesis. Mutations in a regulatory subunit of AMP-activated protein kinase...

Detaylı Bibliyografya
Asıl Yazarlar:	Ashrafian, H, Watkins, H
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2005

Benzer Materyaller

Myocardial dysfunction in hypertrophic cardiomyopathy.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

The genetics of hypertrophic cardiomyopathy: Teare redux.
Yazar:: Watkins, H, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Sudden death in hypertrophic cardiomyopathy.
Yazar:: Watkins, H
Baskı/Yayın Bilgisi: (2000)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
Yazar:: Abozguia, K, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy
Yazar:: Toepfer, CN, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Exercise-induced ventricular dysfunction in hypertrophic cardiomyopathy: stunning by any other name?
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Impaired left ventricular energy metabolism in hypertrophic cardiomyopathy is not due to fibrosis.
Yazar:: Petersen, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
Yazar:: Hudsmith, L, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Linked genetic modifiers in hypertrophic cardiomyopathy
Yazar:: Ektisham, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Metabolic Modulation With Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy
Yazar:: Abozguia, K, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
Yazar:: Watkins, H
Baskı/Yayın Bilgisi: (2003)

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.
Yazar:: Abozguia, K, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
Yazar:: Raj Murthi, S, ve diğerleri
Baskı/Yayın Bilgisi: (2025)

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.
Yazar:: Watkins, H, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management
Yazar:: Watkins, H
Baskı/Yayın Bilgisi: (2001)

Assigning a causal role to genetic variants in hypertrophic cardiomyopathy.
Yazar:: Watkins, H
Baskı/Yayın Bilgisi: (2013)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Is DNA testing for hypertrophic cardiomyopathy cost-effective?
Yazar:: Wordsworth, S, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Mutations in the gamma2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
Yazar:: Kramer, CM, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
Yazar:: Suttie, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The genetic architecture of hypertrophic cardiomyopathy
Yazar:: Harper, AR
Baskı/Yayın Bilgisi: (2020)

The role of cardiac energy metabolism and during stress in hypertrophic and dilated cardiomyopathy.
Yazar:: Dass, S
Baskı/Yayın Bilgisi: (2012)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
Yazar:: Abdulrazzak, H, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Hypertrophic cardiomyopathy mutations in the gamma 2 subunit of AMP-activated kinase suggest a central role of energy compromise in disease pathogenesis
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Inherited cardiomyopathies.
Yazar:: Watkins, H, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Inherited cardiomyopathies.
Yazar:: Watkins, H, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
Yazar:: Toepfer, C, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
Yazar:: Wordsworth, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
Yazar:: Wordsworth, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.
Yazar:: Crilley, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
Yazar:: Rayner, JJ, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

ACUTE DERANGEMENT OF CARDIAC ENERGY METABOLISM AND OXYGENATION DURING STRESS IN HYPERTROPHIC CARDIOMYOPATHY-A POTENTIAL MECHANISM FOR SUDDEN CARDIAC DEATH
Yazar:: Dass, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)